← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 29, 2017Last known activity
May 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT05173896Overall official - principal investigatorPhase 2May 31, 2022
- NCT03151343Lead sponsorPhase 3Mar 29, 2017
Details
- Last known activity
- May 31, 2022